Cotinga Pharmaceuticals   Report issue

For profit Phase 1
Founded: London United Kingdom (1999)
Status: Defunct (2021)

Organization Overview

First Clinical Trial
2015
NCT02433626
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Critical Outcome Technologies Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

coti2 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Endometrial Neoplasms (Phase 1)

Fallopian Tube Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1